Nocturnal GERD Tied to Non-Infectious Rhinitis

This article originally appeared here.
Share this content:
Nocturnal GERD Tied to Non-Infectious Rhinitis
Nocturnal GERD Tied to Non-Infectious Rhinitis

FRIDAY, March 27, 2015 (HealthDay News) -- Nocturnal gastroesophageal reflux disease (GERD) appears to be a risk factor for non-infectious rhinitis (NIR), according to a study published online March 24 in Allergy.

Linus Schiöler, Ph.D., from the University of Gothenburg in Sweden, and colleagues analyzed data from 5,417 subjects participating in a multicenter longitudinal cohort. Participants completed a questionnaire in 1999 to 2001 and again in 2010 to 2012. NIR was characterized as having nasal obstruction, secretion, and/or sneezing in the absence of the common cold.

The researchers found that, over the 10-year study period, 19.1 percent of participants developed NIR. More NIR was seen in 2010 for participants reporting nocturnal gastroesophageal reflux in both 1999 and 2010 (2.8 versus 1.2 percent; P < 0.001). The number of reflux episodes/week in 1999 and the risk of having NIR in 2010 demonstrated a significant dose-response relationship (P = 0.02). Those with nocturnal GERD in 1999 (at least three episodes of nocturnal gastroesophageal reflux symptoms per week) had an increased odds of developing NIR in 2010 (odds ratio, 1.6; P = 0.03), when adjusting for age, gender, body mass index, tobacco smoke and asthma. There was an increased risk of developing NIR (P < 0.001) and nocturnal GERD associated with smoking.

"GERD should therefore be considered in patients with rhinitis of known and unknown origin," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »